drugset / Trial / NCT04961905

Pharmacokinetic Characteristics and Safety After Administration of NVP-2002

NCT04961905 ↗

Phase 1 Completed 96 enrolled NVP Healthcare
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to compare and evaluate the pharmacokinetic characteristics and safety after administration of NVP-2002 and co-administration of NVP-2002-R1 and NVP-2002-R2 in healthy adult volunteers.

Timeline

Start
2022-09-03
Primary completion
2023-04-25
Completion
2023-05-30

Drugs

EvaluationDrugModalityDoseRoute
Subject NVP-2002 Unknown — —
Subject NVP-2002-R1 Unknown — —
Subject NVP-2002-R2 Unknown — —

Indications

No indication recorded.